European Journal of Plastic Surgery

, Volume 30, Issue 1, pp 7–9

What is the role of CT staging in the management of patients with clinical stage 1 and 2 malignant melanoma?

  • Emily Newton-Dunn
  • Matthew Kok-Hao Hong
  • Michael Kok-Yee Hong
  • Christopher Stone
Original Paper

DOI: 10.1007/s00238-007-0127-9

Cite this article as:
Newton-Dunn, E., Kok-Hao Hong, M., Kok-Yee Hong, M. et al. Eur J Plast Surg (2007) 30: 7. doi:10.1007/s00238-007-0127-9

Abstract

There is a lack of evidence to support CT staging for distant disease in patients with Clinical Stage I and II melanoma. Staging scans, undertaken prior to Sentinel Lymph Node Biopsy (SLNB) in 115 patients with melanoma, between October 2004 and October 2006 were reviewed. CT imaging failed to identify distant site disease in any patient. 67 patients were diagnosed with non-melanoma related abnormalities necessitating further imaging and investigation, ultimately without identifiable benefit in all but one patient. The results of this study further question the need for distant site imaging of melanoma patients prior to SLNB.

Keywords

Malignant melanomaComputerised tomographyManagement of patients

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Emily Newton-Dunn
    • 1
  • Matthew Kok-Hao Hong
    • 1
  • Michael Kok-Yee Hong
    • 1
  • Christopher Stone
    • 1
  1. 1.Department of Plastic SurgeryRoyal Devon and Exeter HospitalDevonUK